IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside.

MLA

Vahidi, Sogand, et al. “IL-15 as a Key Regulator in NK Cell-Mediated Immunotherapy for Cancer: From Bench to Bedside.” International Immunopharmacology, vol. 133, May 2024, p. 112156. EBSCOhost, https://doi.org/10.1016/j.intimp.2024.112156.

APA

Vahidi, S., Zabeti Touchaei, A., & Samadani, A. A. (2024). IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside. International Immunopharmacology, 133, 112156. https://doi.org/10.1016/j.intimp.2024.112156

Chicago

Vahidi, Sogand, Arefeh Zabeti Touchaei, and Ali Akbar Samadani. 2024. “IL-15 as a Key Regulator in NK Cell-Mediated Immunotherapy for Cancer: From Bench to Bedside.” International Immunopharmacology 133 (May): 112156. doi:10.1016/j.intimp.2024.112156.